21.2 Acute Liver Failure & Severe Acute Pancreatitis

Acute Liver Failure: Definitions, Classification, and Etiological Phenotypes

Acute Liver Failure (ALF) is defined as the rapid development of severe acute liver cell injury manifested by coagulopathy (INR $\ge 1.5$) and any degree of hepatic encephalopathy in a patient without prior pre-existing cirrhosis or underlying chronic liver disease, with a disease duration of less than 26 weeks.

Temporal Classification Phenotypes

ALF is categorized into three clinical phenotypes based on the time interval elapsed between the initial onset of jaundice and the first manifestation of hepatic encephalopathy:

[Interval: Jaundice Onset to Hepatic Encephalopathy]

0 days ───────────── 7 days ─────────────────── 4 weeks ──────────────────── 12 weeks
  │                   │                          │                            │
  └─── Hyperacute ────┴────────── Acute ─────────┴───────── Subacute ─────────┘
       • Acetaminophen           • Acute Viral HBV         • Idiosyncratic DILI
       • Ischemia / Shock          (Jaundice to Enceph:      • Indeterminate / Autoimmune
       • High AST/ALT (>5000)      1 to 4 weeks)           • Moderate Jaundice / Low AST
       • High Cerebral Edema                               • Low Cerebral Edema Risk
       • Spontaneous Survival: ~60%                        • Spontaneous Survival: <20%

1. Hyperacute Liver Failure ($<7\text{ days}$):
   • Primary Etiologies: Acetaminophen toxicity, acute ischemic hepatitis ("shock liver"), hepatic ischemia, viral hepatitis A and E, and Amanita phalloides mushroom toxicity.
   • Clinical Features: Massive transaminase elevations (often $\text{AST/ALT} > 5,000-10,000\text{ U/L}$), rapid onset of profound coagulopathy (INR $> 3-5$), relatively mild hyperbilirubinemia at onset, and extremely high risk of cerebral edema and intracranial hypertension ($>70\%$ in Grade IV encephalopathy).
   • Prognosis: Paradoxically carries the highest rate of spontaneous transplant-free recovery ($>50-60\%$) with aggressive supportive care.
2. Acute Liver Failure ($1 - 4\text{ weeks}$):
   • Primary Etiologies: Acute viral hepatitis B (often with Delta co-infection) and reactivation.
   • Clinical Features: Moderate transaminase elevations, progressive deepening jaundice, and moderate risk of cerebral edema. Spontaneous transplant-free survival is approximately $25-30\%$.
3. Subacute Liver Failure ($4 - 12\text{ weeks}$):
   • Primary Etiologies: Idiosyncratic drug-induced liver injury (DILI; e.g., antimicrobials like amoxicillin-clavulanate, isoniazid, nitrofurantoin; antiepileptics; non-steroidal anti-inflammatory drugs) and indeterminate / seronegative hepatitis.
   • Clinical Features: Marked, deep jaundice (bilirubin often $>20\text{ mg/dL}$), relatively modest transaminase elevations ($<1,000-2,000\text{ U/L}$), ascites, and wasting. Cerebral edema is infrequent, but spontaneous recovery is extremely poor ($<15-20\%$), making early transplant evaluation imperative.

---

Acetaminophen Toxicity and N-Acetylcysteine (NAC) Protocols

Acetaminophen (paracetamol) toxicity is the leading cause of acute liver failure in North America and Western Europe, responsible for nearly 50% of all ALF cases.

Pathophysiological Cascade

At therapeutic doses, $90\%$ of acetaminophen undergoes hepatic Phase II glucuronidation and sulfation into non-toxic metabolites. Approximately $5-10\%$ is oxidized by cytochrome P450 enzymes (predominantly CYP2E1) into the highly reactive, cytotoxic electrophile N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is instantaneously conjugated with intracellular glutathione to form non-toxic mercapturic acid conjugates excreted in urine.

In acute overdose, glucuronidation and sulfation pathways saturate. Excessive drug is shunted through CYP2E1, producing massive quantities of NAPQI that rapidly deplete intrahepatic glutathione stores. When glutathione drops below $30\%$ of normal baseline, unbound NAPQI binds covalently to cysteinyl sulfhydryl groups on hepatocyte mitochondrial proteins. This triggers mitochondrial oxidative stress, opening of the mitochondrial permeability transition (MPT) pore, collapse of mitochondrial membrane potential, loss of ATP synthesis, and necrotic lysis concentrated in centrilobular hepatocytes (Zone 3 necrosis).

Rumack-Matthew Nomogram

For a single acute ingestion presenting between 4 and 24 hours post-ingestion, serum acetaminophen concentration must be plotted against time on the Rumack-Matthew Nomogram. The United States "treatment line" starts at $150\ \mu\text{g/mL}$ ($1000\ \mu\text{mol/L}$) at 4 hours post-ingestion and extends to $37.5\ \mu\text{g/mL}$ at 12 hours. If the serum level falls at or above this line, immediate N-acetylcysteine therapy is mandatory.

Intravenous N-Acetylcysteine (NAC) Regimen

N-acetylcysteine acts as a glutathione precursor (supplying L-cysteine for glutathione synthesis), scavenges free radicals, and enhances microvascular oxygen delivery. The standard intravenous Prescott protocol delivers $300\text{ mg/kg}$ total over 21 hours in three bags:

• Bag 1: $150\text{ mg/kg}$ IV in $200\text{ mL}$ $5\%$ dextrose in water (D5W) infused over 60 minutes.
• Bag 2: $50\text{ mg/kg}$ IV in $500\text{ mL}$ D5W infused over 4 hours ($12.5\text{ mg/kg/h}$).
• Bag 3: $100\text{ mg/kg}$ IV in $1000\text{ mL}$ D5W infused over 16 hours ($6.25\text{ mg/kg/h}$).

Mandatory Continuation Criteria: NAC must never be discontinued automatically at 21 hours. Repeat liver function tests, INR, and acetaminophen level prior to completing Bag 3. Continue the Bag 3 infusion ($6.25\text{ mg/kg/h}$) without interruption if:

1. Transaminases (ALT/AST) remain significantly elevated or are continuing to rise; OR
2. Coagulopathy persists (INR $> 1.5-2.0$); OR
3. Serum acetaminophen remains detectable.

Continue NAC until ALT is clearly and consistently declining, INR is $<2.0$, and the patient is clinically stable.

NAC in Non-Acetaminophen ALF: The landmark prospective randomized trial by Lee et al. (Gastroenterology 2009) demonstrated that intravenous NAC significantly improves transplant-free survival (40% vs. 27%; $P = 0.043$) in patients presenting with early-stage (Grade I-II encephalopathy) non-acetaminophen ALF. NAC reduces systemic vasodilation, improves tissue oxygen extraction, and mitigates hepatic microvascular ischemia.

---

Prognostic Stratification: The King's College Criteria

Prompt referral to a dedicated liver transplant center is critical. The King's College Criteria remain the most widely validated and utilized decision-support criteria worldwide for identifying patients with ALF who have a $<15-20\%$ chance of spontaneous survival and require immediate listing for emergency liver transplantation.

---

Neurocritical Care and Cerebral Edema in Acute Liver Failure

Cerebral edema leading to intracranial hypertension (elevated ICP) and subsequent uncal or tonsillar brain herniation is the leading cause of mortality in patients with hyperacute liver failure.

[Arterial Hyperammonemia (>150-200 µmol/L)]
                   │
       Crosses Blood-Brain Barrier
                   │
   Astrocyte Glutamine Synthetase:
   Ammonia + Glutamate ──> Glutamine Accumulation
                   │
   Intracellular Osmotic Gradient
   Free Water Enters Astrocytes
                   │
   Cytotoxic Astrocyte Swelling
                   │
   Elevated Intracranial Pressure (ICP > 20 mmHg)
                   │
   Decreased Cerebral Perfusion Pressure (CPP = MAP - ICP < 50-60 mmHg)
                   │
   Fatal Brain Herniation / Ischemia

Pathophysiology of Hyperammonemia

Failing hepatocytes lose the enzymatic machinery of the urea cycle, resulting in systemic accumulation of ammonia. Free ammonia ($NH_3$) freely crosses the blood-brain barrier. Within cerebral astrocytes, ammonia is detoxified by glutamine synthetase, which couples ammonia with glutamate to synthesize glutamine. Glutamine acts as a potent intracellular osmolyte. Excessive astrocytic glutamine accumulation generates an intracellular osmotic gradient, drawing free water into astrocytes and producing cytotoxic cerebral edema. In addition, hyperammonemia induces cerebral hyperemia through impaired vascular autoregulation.

Arterial ammonia levels correlate directly with herniation risk:

• Ammonia $<100\ \mu\text{mol/L}$: Minimal risk of cerebral edema.
• Ammonia $150-200\ \mu\text{mol/L}$: Significant risk of intracranial hypertension.
• Ammonia $>200\ \mu\text{mol/L}$: Strongly associated with intracranial hypertension and cerebral herniation.

Neuroprotective Management Protocol

1. Airway Protection: Elective endotracheal intubation is mandatory upon transition to Grade III (confusion, somnolence, marked confusion) or Grade IV (coma) hepatic encephalopathy.
2. Head Elevation and Positioning: Maintain head of bed elevated at $30^\circ$ with midline neck positioning to optimize cerebral venous outflow through the internal jugular veins.
3. Targeted Osmotherapy: Continuous infusion of $3\%$ hypertonic saline targeted to achieve a serum sodium level of $145-150\text{ mEq/L}$. Prophylactic hypernatremia significantly reduces the frequency and magnitude of ICP spikes compared to standard fluid management. Boluses of $20\%$ mannitol ($0.5-1.0\text{ g/kg}$ IV over 15 minutes) are reserved for acute ICP spikes, provided serum osmolality is $<320\text{ mOsm/kg}$ and oliguric renal failure is absent.
4. Early Continuous Renal Replacement Therapy (CRRT): Continuous venovenous hemodiafiltration (CVVHDF) should be instituted early—even in the absence of traditional renal failure indications—whenever arterial ammonia exceeds $150\ \mu\text{mol/L}$ or is rising rapidly. High-volume CRRT provides continuous extracorporeal ammonia clearance, corrects metabolic acidosis, and permits strict temperature regulation.
5. Targeted Temperature Management: Fever ($>38^\circ\text{C}$) dramatically accelerates cerebral hyperemia and glutamine accumulation. Maintain strict normothermia ($35.5-36.5^\circ\text{C}$) using surface or endovascular cooling. Mild therapeutic hypothermia ($33-35^\circ\text{C}$) serves as an emergency rescue bridge for refractory intracranial hypertension unresponsive to hyperosmolar therapy.
6. Sedation: Propofol infusion is favored due to its ability to decrease cerebral metabolic oxygen demand ($CMRO_2$), suppress cerebral blood flow, and lower ICP.

---

Severe Acute Pancreatitis: Classification and Resuscitation

Acute pancreatitis (AP) is an acute inflammatory disorder of the pancreas triggered by premature intracellular activation of trypsinogen within acinar cells, causing autodigestion, microvascular thrombosis, and systemic inflammatory response syndrome (SIRS).

The Revised Atlanta Classification

• Mild Acute Pancreatitis: Absence of organ failure and absence of local or systemic complications. Typically resolves within 3 to 5 days.
• Moderately Severe Acute Pancreatitis: Presence of transient organ failure ($<48\text{ hours}$) OR local complications (peripancreatic fluid collections, acute necrotic collections) or systemic exacerbation of pre-existing comorbidities.
• Severe Acute Pancreatitis (SAP): Characterized by persistent organ failure ($>48\text{ hours}$) involving one or multiple organ systems (respiratory, cardiovascular, or renal), defined by a modified Marshall score $\ge 2$.

Fluid Resuscitation Paradigm: The WATERFALL Trial

For decades, conventional guidelines endorsed aggressive crystalloid resuscitation ($10-15\text{ mL/kg/h}$, often totaling $4-6\text{ L}$ in 24 hours). However, the landmark multinational randomized WATERFALL trial (de-Madaria et al., NEJM 2022) conclusively demonstrated that aggressive fluid resuscitation significantly increases clinical harm without improving outcomes:

• Aggressive Arm: $20\text{ mL/kg}$ bolus followed by $3\text{ mL/kg/h}$.
• Moderate Arm: $10\text{ mL/kg}$ bolus only if hypovolemic, followed by $1.5\text{ mL/kg/h}$ of Lactated Ringer's.

The trial was halted early for safety because aggressive resuscitation produced a three-fold increase in fluid overload (20.5% vs. 6.3%; adjusted relative risk 2.85; $P = 0.004$) without any reduction in necrotizing pancreatitis or persistent organ failure.

Current Resuscitation Standard:

• Administer balanced crystalloids (Lactated Ringer's) in preference to normal saline ($0.9\%$ NaCl). Normal saline causes hyperchloremic metabolic acidosis and triggers renal vasoconstriction; Lactated Ringer's reduces SIRS and C-reactive protein levels.
• Resuscitate with moderate goal-directed rates ($1.5-2.0\text{ mL/kg/h}$), adjusted based on dynamic hemodynamic markers, maintaining mean arterial pressure $\ge 65\text{ mmHg}$, urine output $\ge 0.5\text{ mL/kg/h}$, and hemoconcentration resolution (hematocrit $<35-40\%$ and blood urea nitrogen normalization).

---

Nutritional Support and Antimicrobial Stewardship in Pancreatitis

Enteral Nutrition vs. Total Parenteral Nutrition (TPN)

Gut barrier breakdown is the primary driver of secondary pancreatic necrosis infection and multi-organ failure. Total parenteral nutrition (TPN) promotes gut mucosal atrophy, increases bacterial translocation, and is associated with significantly higher rates of infection and mortality.

• Early Enteral Nutrition (EN) initiated within $24-72\text{ hours}$ of admission preserves intestinal mucosal villous height, maintains tight junctions, stimulates mesenteric blood flow, and reduces systemic infectious complications and death.
• Nasogastric (NG) vs. Nasojejunal (NJ) Equivalence: Multiple randomized trials have demonstrated that nasogastric enteral feeding is therapeutically equivalent to post-pyloric nasojejunal feeding in terms of tolerance, aspiration rates, infectious complications, and mortality. NG tube placement is faster, less technically complex, and avoids procedural delays.

Antimicrobial Stewardship: Prophylaxis Strictly Discouraged

Multiple international guidelines (ACG, IAP/APA) strictly recommend against the routine administration of prophylactic intravenous antibiotics in patients with severe acute pancreatitis or sterile necrotizing pancreatitis.

Prophylactic antibiotics do not reduce infected necrosis, do not prevent organ failure, do not decrease surgical interventions, and do not improve mortality. Instead, routine prophylaxis drives the emergence of multi-drug resistant Gram-negative bacilli, carbapenemase-producing Enterobacteriaceae, and lethal invasive fungal superinfections (Candida albicans and glabrata).

---

Infected Necrotizing Pancreatitis: The Minimally Invasive Step-Up Approach

Pancreatic necrosis occurs in approximately $20\%$ of patients with acute pancreatitis. Necrosis is initially sterile, but secondary bacterial infection develops in approximately one-third of necrotizing cases, usually occurring 2 to 4 weeks after symptom onset.

Diagnosis of Infected Necrosis

Infected necrotizing pancreatitis is suspected when a patient develops recurrent fever, rising leukocytosis, escalating inflammatory markers, or new or progressive organ failure after initial clinical stabilization. The pathognomonic finding on contrast-enhanced computed tomography (CECT) is the presence of extraluminal gas bubbles within the pancreatic or peripancreatic necrotic collection.

The Step-Up Approach Protocol (PANTER Trial)

The landmark multicenter randomized PANTER trial (van Santvoort et al., NEJM 2010) established that a minimally invasive "step-up approach" is vastly superior to open surgical necrosectomy. Patients randomized to the step-up approach experienced a $60\%$ reduction in major complications (new-onset multi-organ failure, systemic bleeding, enterocutaneous fistulae), reduced new-onset diabetes ($16\%$ vs. $38\%$), and lower long-term pancreatic exocrine insufficiency.

[Suspected or Confirmed Infected Necrotizing Pancreatitis]
                               │
        Step 1: Broad-Spectrum Intravenous Antibiotics
     (Meropenem 1 g IV q8h or Cefepime + Metronidazole)
                               │
        Step 2: Postpone Invasive Intervention > 4 Weeks
     (Facilitates demarcation into Walled-Off Necrosis [WON])
                               │
        Step 3: Minimally Invasive Catheter Drainage
     (Percutaneous retroperitoneal drain OR Endoscopic cystogastrostomy)
                               │
                Does Patient Improve within 48 - 72 Hours?
                ├── YES ──> Continue drainage (35-40% heal completely!)
                └── NO  ──> Step 4: Minimally Invasive Necrosectomy
                            • Video-Assisted Retroperitoneal Debridement (VARD) OR
                            • Direct Endoscopic Necrosectomy (DEN)

1. Step 1: Targeted Antibiotic Pharmacotherapy: When infected necrosis is documented or strongly suspected, initiate broad-spectrum intravenous antimicrobials that demonstrate excellent pancreatic tissue penetration: carbapenems (meropenem $1\text{ g}$ IV q8h), or high-dose fluoroquinolones/cefepime combined with metronidazole.
2. Step 2: Delayed Intervention: Whenever clinically feasible, invasive procedural interventions should be delayed for at least 4 weeks from symptom onset. This delay permits the acute necrotic collection (ANC) to liquefy, demarcate, and organize a fibrous encapsulating wall, transforming into Walled-Off Necrosis (WON). Intervening on early, unencapsulated, gelatinous retroperitoneal necrosis causes massive intraoperative hemorrhage, incomplete debridement, and catastrophic morbidity.
3. Step 3: Minimally Invasive Drainage: The first interventional step is image-guided drainage: either percutaneous catheter drainage (PCD) placed via a left retroperitoneal approach, or endoscopic transluminal cystogastrostomy drainage utilizing lumen-apposing metal stents (LAMS). Remarkably, $35\%$ to $40\%$ of patients recover completely with catheter drainage alone, entirely avoiding any surgical debridement.
4. Step 4: Minimally Invasive Necrosectomy: If the patient fails to show clinical and physiological improvement within 48 to 72 hours following adequate catheter drainage, step up to minimally invasive surgical necrosectomy: Video-Assisted Retroperitoneal Debridement (VARD) (inserting a rigid laparoscope through the existing percutaneous drain tract to mechanically debride loose necrotic tissue under continuous irrigation) or Direct Endoscopic Necrosectomy (DEN). Primary open laparotomy is strictly reserved for rare refractory salvage cases or mechanical intra-abdominal catastrophes (perforation or abdominal compartment syndrome).